Most sites from which tumors are most likely to metastasize—colorectal, esophageal, lung, ovarian, and pancreatic cancer—had low prevalences of both CDH1 and CTNNB1 mutations. This evidence concerns the gene CTNNB1 and familial pancreatic carcinoma.